CD8A and neoplasm: Moreover, the existence of CD8+ T cells at the tumor invasive margins prior to the initiation of therapy was associated with a favorable ICI response, while the proliferation of intratumoral CD8+ T cells during therapy was correlated with tumor relapse or metastasis (15).